This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 1.04% to $616.31 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.35% to 4,685.25 and Dow Jones Industrial Average falling 0.31% to 36,319.98. Regeneron Pharmaceuticals Inc. closed $70.31 short of its 52-week high ($686.62), which the company achieved on September 3rd.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.22% to $162.51, Novartis AG ADR (NOVN.EB) fell 0.16% to $83.09, and Amgen Inc. (AMGN) rose 0.16% to $211.71. Trading volume (588,364) remained 199,671 below its 50-day average volume of 788,035.
Data source: Dow Jones Market Data, FactSet. Data compiled November 9, 2021.
(END) Dow Jones Newswires
November 09, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.